EGLN3 and anaplastic astrocytoma: Methylation-specific PCR (Supplementary Fig. 1e) revealed that PHD3 CpG sites were methylated in more than 80% of all patients with low-grade and anaplastic astrocytomas as well as secondary glioblastomas (Fig. 1c) and to a lower degree in primary glioblastoma patients.